S. Koopmans

Reproducibility of histologic classification in nonfibrotic myeloproliferative neoplasia.

K. Hebeda, H. de Raeve, K. Lam, 2011, American journal of clinical pathology.

Treatment options for myelofibrosis and myeloproliferative neoplasia

H. Schouten, S. Koopmans, S. M. Koopmans, 2013 .

Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach

A. Kater, S. Koopmans, M. van Gelder, 2017, Haematologica.

BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.

H. Schouten, S. Koopmans, A. V. van Marion, 2015, Histology and histopathology.

Myeloproliferative neoplasia : more insight in the pathogenesis

S. Koopmans, S. M. Koopmans, 2014 .

Myeloproliferative neoplasia: a review of clinical criteria and treatment.

H. Schouten, S. Koopmans, A. V. van Marion, 2012, The Netherlands journal of medicine.

Anti-Apoptotic Pathways in Bone Marrow and Megakaryocytes in Myeloproliferative Neoplasia

H. Schouten, S. Koopmans, A. V. van Marion, 2013, Pathobiology.

The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia.

H. Schouten, S. Koopmans, F. Bot, 2012, American journal of blood research.